Konrad Szymański Cezary Kowalewski Ewelina Pietrzyk Katarzyna Woźniak
10.3389/fimmu.2023.1214011
Front Immunol
2023 Jul 12;14:1214011.
eba ivig epidermolysis bullosa acquisita inflammatory bowel diseases infliximab rituximab
CC BY
https://pubmed.ncbi.nlm.nih.gov/37503352/
Biological Products / therapeutic use Epidermolysis Bullosa Acquisita / diagnosis Epidermolysis Bullosa Acquisita / drug therapy
Biological Products / therapeutic use Epidermolysis Bullosa Acquisita / diagnosis Epidermolysis Bullosa Acquisita / drug therapy Review Case Reports Autoantibodies Blister Dapsone / therapeutic use Humans Autoantibodies Dapsone Biological Products
PMC10371012
37503352
Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review
2023